Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes

Toxicology and Applied Pharmacology

Volumn 163, Issue 2, 2000, Pages 203-207

  Petrick, Jay S ^a   Ayala Fierro, Felix ^a   Cullen, William R ^c   Carter, Dean E ^a   Vasken Aposhian, H ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arsenate; Arsenite; Chang human hepatocytes; Dimethylarsinic acid; DMA; DMA(V); DMPS; LDH; MMA(III); MMA(V); Monomethylarsonic acid; Monomethylarsonous acid; Potassium; XTT

Indexed keywords

ARSENIC ACID; ARSENIC TRIOXIDE; METHANEARSONIC ACID;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; LIVER TOXICITY; MITOCHONDRIAL RESPIRATION; TOXICITY TESTING;

ANIMALIA;

EID: 0034162837     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8872     Document Type: Article

References (28)

1. Aposhian H. V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419.
2. Ayala-Fierro F., Barber D. S., Rael L. T., Carter D. E. In vitro tissue specificity for arsine and arsenite toxicity in the rat. Toxicol. Sci. 52:1999;122-125.
3. Baur H., Kasperek S., Pfaff E. Criteria of viability of isolated liver cells. Hoppe-Seyler's Z. Physiol. Chem. 356:1975;827-838.
4. Burrows G. J., Turner E. E. A new type of compound containing arsenic. J. Chem. Soc. 117:1920;1373-1380.
5. Cullen W. R., McBride B. C., Manji H., Pickett A. W., Reglinski J. The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 3:1989;71-78.
6. Cullen W. R., Reimer K. J. Arsenic speciation in the environment. Chem. Rev. 89:1989;713-764.
7. Da Costa E. W. B. Variation in the toxicity of arsenic compounds to microorganisms and the suppression of the inhibitory effects by phosphate. Appl. Microbiol. 23:1972;46-53.
8. 1 cells. J. Toxicol. Environ. Health. 57:1999;489-505.
9. Dujovne C. A., Zimmerman H. J. Cytotoxicity of phenothiazines on Chang liver cells as measured by enzyme leakage. Proc. Soc. Exp. Biol. Med. 131:1969;583-587.
10. Fischer A. B., Buchet J. P., Lauwerys R. R. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 57:1985;168-172.
11. Fowler B. A. International conference on environmental arsenic: An overview. Environ. Health Perspect. 19:1977;239-242.
12. Goyer R. A. Toxic effects of metals. Klaassen C. D. Casarett and Doull's Toxicology, The Basic Science of Poisons. 1996;696-697 McGraw-Hill, New York.
13. Hindmarsh J. T., McCurdy R. F. Clinical and environmental aspects of arsenic toxicity. CRC Crit. Rev. Clin. Lab. Sci. 23:1986;315-347.
14. Huang R., Lee T. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium. Toxicol. Appl. Pharmacol. 136:1996;243-249.
15. Loveland B. E., Johns T. G., Mackay I. R., Vaillant F., Wang X., Hertzog P. J. Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem. Int. 27:1992;501-510.
16. National Research Council, 1999, Arsenic in Drinking Water, National Academy Press, Washington, D.C.
17. Roehm N. W., Rodgers G. H., Hatfield S. M., Glasebrook A. L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods. 142:1991;257-265.
18. Soignet S. L., Maslak P., Wang Z., Jhanwar S., Calleja E., Dardashti L. J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D. A., Pandolfi P. P., Warrell R.P. Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339:1998;1341-1348.
19. Styblo M., Serves S. V., Cullen W. R., Thomas D. J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33.
20. Thiel T. Phosphate transport and arsenate resistance in the cyanobacterium Anabaena variabilis. J. Bacteriol. 170:1988;1143-1147.
21. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 82:1999;69-88.
22. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem.-Biol. Interact. 47:1983;29-44.
23. Wroblewski F., LaDue J. S. Lactic acid dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90:1955;210-213.
24. Yamanaka K., Hasegawa A., Sawamura R., Hayashi, Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108:1991;205-213.
25. Yamanaka K., Hayahsi H., Kato K., Hasegawa A., Okada S. Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells. Biochem. Biophys. Res. Commun. 207:1995;244-249.
26. V reductase. Chem. Res. Toxicol. 12:1999;1278-1283.
27. III) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15.
28. Zakharyan R., Wu Y., Bogdan G. M., Aposhian H. V. Enzymatic methylation of arsenic compounds: Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 8:1995;1029-1038.